Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.36 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imidazole SCHEMBL28750264 | 0.79 | MAPT (0.50) | ALDH1A1FKBP5TBXAS1ABCC4MAPT | |
| Imidazole SCHEMBL2541492 | 0.78 | ALDH1A1 (0.48) | ALDH1A1FKBP5ALOX15 | |
| Imidazole SCHEMBL29140670 | 0.78 | MAPT (0.49) | ALDH1A1FKBP5TBXAS1ABCC4MAPT | |
| SCHEMBL18828 | 0.77 | — | — | |
| SCHEMBL16618079 | 0.77 | MAPT (0.44) | ALDH1A1TBXAS1ABCC4MAPTALOX15 | |
| Acrylic Acid SCHEMBL28391287 | 0.77 | ALOX15 (0.40) | ALDH1A1FKBP5TBXAS1ALOX15HSD17B10 | |
| Itaconate SCHEMBL5173547 | 0.77 | ALDH1A1 (0.46) | ALDH1A1FKBP5TBXAS1ALOX15HSD17B10 | |
| SCHEMBL11243342 | 0.75 | ABCC4 (0.40) | ALDH1A1TBXAS1ABCC4MAPTALOX15 | |
| SCHEMBL4562517 | 0.75 | MAPT (0.43) | ALDH1A1TBXAS1ABCC4MAPTALOX15 | |
| Fluoride SCHEMBL12006687 | 0.75 | MAPT (0.43) | ALDH1A1TBXAS1ABCC4MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090060859-A1 | IMIDAZOLIUM ALKYL (METH)ACRYLATE POLYMERS | BASF SE (DE) | 2009-03-05 | — | — | US | disclosed |
| US-20090060859-A1 | IMIDAZOLIUM ALKYL (METH)ACRYLATE POLYMERS | BASF SE (DE) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090060859-A1 | IMIDAZOLIUM ALKYL (METH)ACRYLATE POLYMERS | ACR, MMAB, PTEN | ALDH1A1 299/4885FKBP5 8/4885TBXAS1 4322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.